AVE 16.7% 0.3¢ avecho biotechnology limited

cornerstone investors, page-5

  1. 2,801 Posts.
    lightbulb Created with Sketch. 512
    PoS As I see it the patent valuations were needed because there were impairment charges from other patent write downs and an exercise is then completed to see that current carry values [after impairment charges ] are not less than current valuations.The patents were valued as a cash generating unit[POH's terminology]which is specific accounting terminology which I will try and research later.Of course as you have pointed out this information could be of great value to a cornerstone investor.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $3.461K 1.175M

Buyers (Bids)

No. Vol. Price($)
65 101062608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20323507 8
View Market Depth
Last trade - 15.44pm 16/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.